CCA
PFE icon

Childress Capital Advisors’s Pfizer PFE Stock Holding History

Childress Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$744K Buy
26,479
+247
+0.9% +$6.58K 0.13% 114
2025
Q4 		$653K Sell
26,232
-675
-3% -$17K 0.1% 142
2025
Q3 		$686K Buy
26,907
+10,294
+62% +$254K 0.13% 122
2025
Q2 		$403K Sell
16,613
-2,459
-13% -$57.3K 0.1% 147
2025
Q1 		$483K Buy
19,072
+5,378
+39% +$141K 0.14% 107
2024
Q4 		$363K Sell
13,694
-31,257
-70% -$848K 0.1% 136
2024
Q3 		$1.3M Sell
44,951
-982
-2% -$28.6K 0.35% 50
2024
Q2 		$1.29M Buy
45,933
+29,017
+172% +$799K 0.36% 46
2024
Q1 		$469K Sell
16,916
-3,318
-16% -$92.1K 0.14% 99
2023
Q4 		$583K Buy
20,234
+436
+2% +$13.2K 0.17% 80
2023
Q3 		$643K Buy
19,798
+14,286
+259% +$505K 0.21% 71
2023
Q2 		$202K Sell
5,512
-986
-15% -$38.4K 0.09% 72
2023
Q1 		$265K Sell
6,498
-14,138
-69% -$611K 0.12% 71
2022
Q4 		$1.06M Buy
20,636
+2,073
+11% +$99.4K 0.35% 51
2022
Q3 		$825K Sell
18,563
-669
-3% -$32.5K 0.32% 60
2022
Q2 		$1.01M Buy
19,232
+1,768
+10% +$90.1K 0.4% 50
2022
Q1 		$903K Buy
17,464
+2,542
+17% +$132K 0.32% 59
2021
Q4 		$881K Sell
14,922
-2,394
-14% -$119K 0.36% 52
2021
Q3 		$744K Buy
17,316
+4,019
+30% +$178K 0.3% 64
2021
Q2 		$520K Buy
13,297
+41
+0.3% +$1.59K 0.24% 69
2021
Q1 		$480K Buy
13,256
+5,719
+76% +$203K 0.22% 89
2020
Q4 		$277K Buy
+7,537
New +$276K 0.16% 76

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Childress Capital Advisors's PFE Position: Q1 2026 in Review

Childress Capital Advisors increased its Pfizer (PFE) stake by 0.94% in Q1 2026, buying an estimated $6.58K and bringing the position to 26,479 shares worth $744K. The position accounts for 0.13% of the portfolio, ranked #114.

Childress Capital Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.3M in Q3 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Childress Capital Advisors held 26,479 shares of Pfizer worth $744K as of Q1 2026.
  • Childress Capital Advisors bought 247 Pfizer shares in Q1 2026, an estimated $6.58K.
  • Pfizer made up 0.13% of Childress Capital Advisors's portfolio in Q1 2026, its #114 holding.
  • Childress Capital Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Childress Capital Advisors's Pfizer position peaked at $1.3M in Q3 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.